| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.798 | 0.016 | 0.832 | Antiinflammatory | 0.832 0.011 DBMET01852 | DBMET01852 | |
| 0.771 | 0.003 | 0.771 | Non-steroidal antiinflammatory agent | 0.481 0.007 DBMET01852 | ||
| 0.581 | 0.004 | 0.581 | Cyclooxygenase 1 inhibitor | 0.436 0.005 DBMET01852 | ||
| 0.58 | 0.012 | 0.58 | Histamine release inhibitor | 0.438 0.056 DBMET01852 | ||
| 0.563 | 0.023 | 0.584 | Cholesterol antagonist | 0.584 0.021 DBMET01852 | DBMET01852 | |
| 0.458 | 0.005 | 0.458 | Cyclooxygenase inhibitor | 0.343 0.012 DBMET01852 | ||
| 0.401 | 0.006 | 0.401 | Amyloid beta precursor protein antagonist | 0.375 0.008 DBMET01852 | ||
| 0.425 | 0.031 | 0.425 | Lipoxygenase inhibitor | 0.348 0.051 DBMET01852 | ||
| 0.448 | 0.066 | 0.539 | Analgesic | 0.539 0.039 DBMET01852 | DBMET01852 | |
| 0.398 | 0.017 | 0.461 | Anesthetic general | 0.461 0.01 DBMET01852 | DBMET01852 | |
| 0.456 | 0.08 | 0.456 | Caspase 9 stimulant | 0.422 0.099 DBMET01852 | ||
| 0.419 | 0.044 | 0.419 | Aldehyde oxidase inhibitor | 0.368 0.052 DBMET01852 | ||
| 0.391 | 0.02 | 0.409 | Sodium/bile acid cotransporter inhibitor | 0.409 0.014 DBMET01852 | DBMET01852 | |
| 0.387 | 0.043 | 0.508 | Spasmolytic | 0.508 0.022 DBMET01852 | DBMET01852 | |
| 0.316 | 0.012 | 0.316 | Cyclooxygenase 2 inhibitor | 0.231 0.024 DBMET01852 | ||
| 0.397 | 0.093 | 0.512 | Cyclophilin D inhibitor | 0.512 0.047 DBMET01852 | DBMET01852 | |
| 0.35 | 0.046 | 0.35 | Antioxidant | 0.333 0.051 DBMET01852 | ||
| 0.349 | 0.051 | 0.404 | Calcium channel activator | 0.404 0.023 DBMET01852 | DBMET01852 | |
| 0.319 | 0.022 | 0.319 | Gastrin inhibitor | 0.288 0.042 DBMET01852 | ||
| 0.365 | 0.079 | 0.377 | Immunosuppressant | 0.377 0.073 DBMET01852 | DBMET01852 | |
| 0.356 | 0.075 | 0.489 | Transcription factor NF kappa B inhibitor | 0.489 0.046 DBMET01852 | DBMET01852 | |
| 0.293 | 0.016 | 0.341 | Interleukin 6 antagonist | 0.341 0.01 DBMET01852 | DBMET01852 | |
| 0.305 | 0.042 | 0.305 | 5 Hydroxytryptamine uptake stimulant | 0.251 0.079 DBMET01852 | ||
| 0.305 | 0.051 | 0.316 | Hypoglycemic | 0.316 0.048 DBMET01852 | DBMET01852 | |
| 0.28 | 0.027 | 0.28 | Thrombolytic | 0.239 0.036 DBMET01852 | ||
| 0.302 | 0.05 | 0.302 | Superoxide dismutase inhibitor | 0.268 0.064 DBMET01852 | ||
| 0.295 | 0.05 | 0.425 | Hypolipemic | 0.425 0.021 DBMET01852 | DBMET01852 | |
| 0.241 | 0.01 | 0.241 | Mediator release inhibitor | 0.139 0.034 DBMET01852 | ||
| 0.243 | 0.015 | 0.245 | ATPase inhibitor | 0.245 0.015 DBMET01852 | DBMET01852 | |
| 0.24 | 0.021 | 0.24 | Interleukin 1 antagonist | 0.153 0.055 DBMET01852 | ||
| 0.22 | 0.009 | 0.22 | Photosensitizer | 0.151 0.031 DBMET01852 | ||
| 0.268 | 0.061 | 0.268 | Free radical scavenger | 0.237 0.074 DBMET01852 | ||
| 0.225 | 0.02 | 0.225 | Chelator | 0.156 0.034 DBMET01852 | ||
| 0.221 | 0.017 | 0.232 | Arachidonic acid antagonist | 0.232 0.011 DBMET01852 | DBMET01852 | |
| 0.223 | 0.025 | 0.223 | MAO A inhibitor | |||
| 0.209 | 0.011 | 0.209 | Mucolytic | 0.178 0.019 DBMET01852 | ||
| 0.25 | 0.068 | 0.25 | Tyrosine 3 hydroxylase inhibitor | 0.204 0.128 DBMET01852 | ||
| 0.245 | 0.064 | 0.245 | Interleukin antagonist | 0.196 0.086 DBMET01852 | ||
| 0.279 | 0.103 | 0.288 | Antithrombotic | 0.288 0.097 DBMET01852 | DBMET01852 | |
| 0.199 | 0.025 | 0.199 | Cell adhesion inhibitor | 0.151 0.046 DBMET01852 | ||
| 0.241 | 0.074 | 0.241 | Calpain inhibitor | |||
| 0.204 | 0.039 | 0.204 | MAO inhibitor | |||
| 0.183 | 0.024 | 0.183 | Expectorant | 0.153 0.034 DBMET01852 | ||
| 0.224 | 0.067 | 0.228 | Amyloid beta aggregation inhibitor | 0.228 0.065 DBMET01852 | DBMET01852 | |
| 0.295 | 0.139 | 0.342 | Antibacterial | 0.342 0.107 DBMET01852 | DBMET01852 | |
| 0.165 | 0.012 | 0.165 | Keratolytic | 0.164 0.012 DBMET01852 | ||
| 0.314 | 0.163 | 0.314 | Apoptosis agonist | 0.314 0.163 DBMET01852 | ||
| 0.176 | 0.03 | 0.21 | Cyclooxygenase 3 inhibitor | 0.21 0.015 DBMET01852 | DBMET01852 | |
| 0.155 | 0.01 | 0.155 | Ornithine decarboxylase inhibitor | 0.138 0.015 DBMET01852 | ||
| 0.143 | 0.003 | 0.143 | DNA helicase inhibitor | 0.118 0.004 DBMET01852 | ||
| 0.205 | 0.068 | 0.205 | Platelet adhesion inhibitor | 0.163 0.093 DBMET01852 | ||
| 0.195 | 0.06 | 0.215 | Lipocortins synthesis antagonist | 0.215 0.048 DBMET01852 | DBMET01852 | |
| 0.148 | 0.015 | 0.148 | Cell adhesion molecule inhibitor | 0.093 0.04 DBMET01852 | ||
| 0.25 | 0.118 | 0.36 | Interleukin 2 agonist | 0.36 0.041 DBMET01852 | DBMET01852 | |
| 0.158 | 0.027 | 0.171 | Ca2+-transporting ATPase inhibitor | 0.171 0.012 DBMET01852 | DBMET01852 | |
| 0.131 | 0.004 | 0.131 | Retinoid X alpha receptor agonist | 0.095 0.005 DBMET01852 | ||
| 0.196 | 0.069 | 0.239 | Nitric oxide antagonist | 0.239 0.055 DBMET01852 | DBMET01852 | |
| 0.192 | 0.07 | 0.348 | Hepatoprotectant | 0.348 0.019 DBMET01852 | DBMET01852 | |
| 0.184 | 0.063 | 0.184 | Succinate dehydrogenase inhibitor | 0.153 0.108 DBMET01852 | ||
| 0.143 | 0.026 | 0.143 | Estrogen antagonist | 0.127 0.043 DBMET01852 | ||
| 0.17 | 0.055 | 0.17 | Lipid peroxidase inhibitor | |||
| 0.115 | 0.004 | 0.115 | ATM kinase inhibitor | 0.065 0.005 DBMET01852 | ||
| 0.126 | 0.015 | 0.147 | Bile acid receptor antagonist | 0.147 0.008 DBMET01852 | DBMET01852 | |
| 0.158 | 0.051 | 0.175 | Adenylate cyclase stimulant | 0.175 0.031 DBMET01852 | DBMET01852 | |
| 0.148 | 0.04 | 0.148 | Vanilloid 1 agonist | 0.131 0.065 DBMET01852 | ||
| 0.254 | 0.147 | 0.254 | Calpain 2 inhibitor | |||
| 0.137 | 0.03 | 0.137 | HIV-1 integrase (Overall Integration) inhibitor | 0.122 0.038 DBMET01852 | ||
| 0.166 | 0.061 | 0.166 | Phospholipase A2 inhibitor | 0.13 0.101 DBMET01852 | ||
| 0.156 | 0.052 | 0.156 | Sphingosine 1-phosphate receptor 5 antagonist | 0.127 0.106 DBMET01852 | ||
| 0.114 | 0.016 | 0.114 | T cell inhibitor | |||
| 0.139 | 0.042 | 0.145 | Interleukin 8 antagonist | 0.145 0.037 DBMET01852 | DBMET01852 | |
| 0.164 | 0.066 | 0.164 | Protein-tyrosine phosphatase inhibitor | 0.14 0.089 DBMET01852 | ||
| 0.162 | 0.065 | 0.162 | Hexokinase inhibitor | 0.156 0.072 DBMET01852 | ||
| 0.15 | 0.055 | 0.279 | Alpha-N-acetylglucosaminidase inhibitor | 0.279 0.019 DBMET01852 | DBMET01852 | |
| 0.123 | 0.029 | 0.123 | Estrogen receptor beta antagonist | 0.114 0.04 DBMET01852 | ||
| 0.142 | 0.049 | 0.183 | Cholesterol synthesis inhibitor | 0.183 0.031 DBMET01852 | DBMET01852 | |
| 0.108 | 0.016 | 0.108 | Aldose reductase inhibitor | 0.073 0.026 DBMET01852 | ||
| 0.121 | 0.03 | 0.147 | ABCA1 expression enhancer | 0.147 0.018 DBMET01852 | DBMET01852 | |
| 0.112 | 0.021 | 0.112 | Estrogen receptor alpha antagonist | 0.1 0.027 DBMET01852 | ||
| 0.093 | 0.005 | 0.093 | Retinoid X receptor agonist | 0.068 0.011 DBMET01852 | ||
| 0.096 | 0.013 | 0.096 | Peroxisome proliferator-activated receptor alpha agonist | 0.047 0.034 DBMET01852 | ||
| 0.154 | 0.073 | 0.154 | Interferon gamma antagonist | 0.146 0.083 DBMET01852 | ||
| 0.115 | 0.036 | 0.128 | Triose-phosphate isomerase inhibitor | 0.128 0.028 DBMET01852 | DBMET01852 | |
| 0.086 | 0.007 | 0.086 | CXC chemokine 1 receptor antagonist | 0.073 0.011 DBMET01852 | ||
| 0.184 | 0.107 | 0.184 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.136 | 0.063 | 0.136 | Sphingosine 1-phosphate receptor 2 antagonist | 0.12 0.097 DBMET01852 | ||
| 0.175 | 0.104 | 0.193 | Neurotrophic factor enhancer | 0.193 0.084 DBMET01852 | DBMET01852 | |
| 0.092 | 0.021 | 0.092 | Peroxisome proliferator-activated receptor gamma antagonist | 0.069 0.057 DBMET01852 | ||
| 0.124 | 0.054 | 0.124 | TRPA1 agonist | 0.109 0.073 DBMET01852 | ||
| 0.12 | 0.05 | 0.12 | 5-Lipoxygenase inhibitor | 0.082 0.079 DBMET01852 | ||
| 0.126 | 0.059 | 0.126 | Protein-tyrosine phosphatase 1B inhibitor | 0.114 0.067 DBMET01852 | ||
| 0.08 | 0.015 | 0.08 | Plasminogen activator inhibitor antagonist | 0.045 0.039 DBMET01852 | ||
| 0.069 | 0.004 | 0.069 | Retinoid X receptor antagonist | 0.058 0.007 DBMET01852 | ||
| 0.078 | 0.013 | 0.078 | Thromboxane synthase inhibitor | 0.075 0.014 DBMET01852 | ||
| 0.09 | 0.026 | 0.09 | Leukotriene antagonist | 0.073 0.038 DBMET01852 | ||
| 0.157 | 0.093 | 0.166 | Phospholipase C inhibitor | 0.166 0.078 DBMET01852 | DBMET01852 | |
| 0.081 | 0.019 | 0.081 | Thromboxane antagonist | |||
| 0.074 | 0.014 | 0.074 | Glucose-6-phosphate translocase inhibitor | 0.074 0.013 DBMET01852 | ||
| 0.088 | 0.028 | 0.088 | GABA B receptor agonist | 0.083 0.036 DBMET01852 | ||
| 0.113 | 0.054 | 0.113 | MAO B inhibitor | |||
| 0.147 | 0.09 | 0.147 | Heat shock protein 90 alpha antagonist | |||
| 0.167 | 0.11 | 0.167 | Anticonvulsant | 0.156 0.122 DBMET01852 | ||
| 0.095 | 0.039 | 0.095 | Vanilloid agonist | 0.083 0.063 DBMET01852 | ||
| 0.06 | 0.004 | 0.06 | Retinoid X alpha receptor antagonist | 0.05 0.006 DBMET01852 | ||
| 0.091 | 0.035 | 0.091 | Glutamate decarboxylase inhibitor | |||
| 0.118 | 0.063 | 0.118 | Caspase 3 inhibitor | |||
| 0.166 | 0.112 | 0.166 | Insulin sensitizer | |||
| 0.074 | 0.019 | 0.074 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.063 0.026 DBMET01852 | ||
| 0.089 | 0.035 | 0.089 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.11 | 0.059 | 0.11 | DOPA decarboxylase inhibitor | |||
| 0.092 | 0.042 | 0.092 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.068 0.063 DBMET01852 | ||
| 0.111 | 0.063 | 0.111 | GABA C receptor antagonist | 0.094 0.088 DBMET01852 | ||
| 0.107 | 0.06 | 0.107 | GABA C receptor agonist | 0.089 0.08 DBMET01852 | ||
| 0.104 | 0.057 | 0.106 | Anabolic | 0.106 0.054 DBMET01852 | DBMET01852 | |
| 0.086 | 0.039 | 0.086 | GABA aminotransferase inhibitor | 0.074 0.054 DBMET01852 | ||
| 0.068 | 0.023 | 0.068 | Thromboxane A2 antagonist | |||
| 0.17 | 0.126 | 0.183 | Platelet antagonist | 0.183 0.115 DBMET01852 | DBMET01852 | |
| 0.074 | 0.032 | 0.079 | Glutamate (mGluR6) antagonist | 0.079 0.025 DBMET01852 | DBMET01852 | |
| 0.082 | 0.041 | 0.082 | CDC25A inhibitor | |||
| 0.06 | 0.022 | 0.06 | CD45 antagonist | |||
| 0.069 | 0.034 | 0.069 | Prostaglandin EP2 antagonist | 0.059 0.042 DBMET01852 | ||
| 0.136 | 0.103 | 0.152 | Melanin inhibitor | 0.152 0.079 DBMET01852 | DBMET01852 | |
| 0.063 | 0.03 | 0.067 | Ryanodine receptor antagonist | 0.067 0.021 DBMET01852 | DBMET01852 | |
| 0.049 | 0.016 | 0.049 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.205 | 0.173 | 0.296 | Apoptosis antagonist | 0.296 0.088 DBMET01852 | DBMET01852 | |
| 0.073 | 0.041 | 0.073 | Selectin antagonist | |||
| 0.052 | 0.02 | 0.052 | Geranyltranstransferase inhibitor | |||
| 0.046 | 0.014 | 0.046 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.052 | 0.02 | 0.069 | AICAR transformylase inhibitor | 0.069 0.01 DBMET01852 | DBMET01852 | |
| 0.035 | 0.004 | 0.035 | Retinoid X beta receptor antagonist | 0.027 0.005 DBMET01852 | ||
| 0.073 | 0.042 | 0.073 | Leukotriene synthesis inhibitor | 0.062 0.052 DBMET01852 | ||
| 0.045 | 0.014 | 0.045 | VCAM-1 antagonist | |||
| 0.045 | 0.014 | 0.045 | VCAM antagonist | |||
| 0.084 | 0.055 | 0.089 | Estrogen-related receptor beta agonist | 0.089 0.043 DBMET01852 | DBMET01852 | |
| 0.067 | 0.041 | 0.067 | CDC25B inhibitor | |||
| 0.051 | 0.024 | 0.051 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.034 | 0.008 | 0.034 | Retinoid X gamma receptor antagonist | 0.032 0.01 DBMET01852 | ||
| 0.106 | 0.08 | 0.111 | Microtubule formation inhibitor | 0.111 0.072 DBMET01852 | DBMET01852 | |
| 0.089 | 0.063 | 0.089 | Thioredoxin inhibitor | 0.089 0.064 DBMET01852 | ||
| 0.041 | 0.015 | 0.041 | Free fatty acid receptor 1 antagonist | 0.032 0.027 DBMET01852 | ||
| 0.159 | 0.135 | 0.161 | Antiamyloidogenic | 0.161 0.133 DBMET01852 | DBMET01852 | |
| 0.106 | 0.082 | 0.129 | Alkylator | 0.129 0.06 DBMET01852 | DBMET01852 | |
| 0.055 | 0.032 | 0.055 | Aconitate hydratase inhibitor | |||
| 0.048 | 0.026 | 0.048 | Macrophage elastase inhibitor | 0.044 0.03 DBMET01852 | ||
| 0.054 | 0.033 | 0.055 | Estrogen agonist | 0.055 0.032 DBMET01852 | DBMET01852 | |
| 0.12 | 0.099 | 0.168 | Cell wall synthesis inhibitor | 0.168 0.049 DBMET01852 | DBMET01852 | |
| 0.091 | 0.071 | 0.092 | Creatine kinase inhibitor | 0.092 0.069 DBMET01852 | DBMET01852 | |
| 0.035 | 0.015 | 0.035 | Liver X receptor beta antagonist | |||
| 0.03 | 0.014 | 0.03 | CXC chemokine 2 receptor antagonist | |||
| 0.041 | 0.025 | 0.041 | AMPA 4 receptor antagonist | 0.036 0.035 DBMET01852 | ||
| 0.186 | 0.17 | 0.186 | Hypoxia-inducible factor 1 alpha inhibitor | 0.185 0.172 DBMET01852 | ||
| 0.037 | 0.022 | 0.037 | AMPA receptor agonist | |||
| 0.198 | 0.184 | 0.286 | Vasodilator, coronary | 0.286 0.099 DBMET01852 | DBMET01852 | |
| 0.056 | 0.042 | 0.056 | Aminopeptidase microsomal inhibitor | |||
| 0.06 | 0.047 | 0.06 | NMDA receptor agonist | |||
| 0.052 | 0.04 | 0.06 | Sphingosine 1-phosphate receptor 5 agonist | 0.06 0.025 DBMET01852 | DBMET01852 | |
| 0.041 | 0.029 | 0.052 | Liver X receptor alpha agonist | 0.052 0.018 DBMET01852 | DBMET01852 | |
| 0.033 | 0.02 | 0.033 | ATP citrate lysase inhibitor | |||
| 0.024 | 0.013 | 0.024 | ICAM 1 antagonist | |||
| 0.074 | 0.064 | 0.089 | Histamine H1 receptor antagonist | 0.089 0.049 DBMET01852 | DBMET01852 | |
| 0.053 | 0.042 | 0.067 | Alcohol oxidase inhibitor | 0.067 0.031 DBMET01852 | DBMET01852 | |
| 0.167 | 0.158 | 0.167 | RNA-directed DNA polymerase inhibitor | |||
| 0.033 | 0.024 | 0.033 | Melatonin receptor 1A agonist | |||
| 0.054 | 0.045 | 0.054 | Aromatase inhibitor | |||
| 0.038 | 0.03 | 0.038 | Retinoic acid alpha receptor agonist | |||
| 0.046 | 0.039 | 0.046 | Topoisomerase II beta inhibitor | |||
| 0.066 | 0.059 | 0.066 | Porphobilinogen synthase inhibitor | |||
| 0.02 | 0.014 | 0.02 | Retinoic acid alpha receptor antagonist | |||
| 0.035 | 0.029 | 0.035 | 5-Alpha-reductase inhibitor | |||
| 0.018 | 0.013 | 0.018 | Factor IX inhibitor | |||
| 0.05 | 0.046 | 0.05 | Beta tubulin antagonist | |||
| 0.019 | 0.016 | 0.019 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.135 | 0.131 | 0.135 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.185 | 0.182 | 0.228 | Immunomodulator | 0.228 0.134 DBMET01852 | DBMET01852 | |
| 0.069 | 0.066 | 0.076 | Vanilloid 4 agonist | 0.076 0.049 DBMET01852 | DBMET01852 | |
| 0.05 | 0.047 | 0.058 | Argininosuccinate synthase inhibitor | 0.058 0.038 DBMET01852 | DBMET01852 | |
| 0.114 | 0.112 | 0.118 | Mannose-6-phosphate isomerase inhibitor | 0.118 0.104 DBMET01852 | DBMET01852 | |
| 0.027 | 0.025 | 0.027 | Liver X receptor alpha antagonist | |||
| 0.021 | 0.019 | 0.021 | Retinoid X gamma receptor agonist | |||
| 0.084 | 0.083 | 0.084 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.118 | 0.117 | 0.118 | Heat shock protein 90 antagonist | |||
| 0.032 | 0.031 | 0.032 | Nicotinic acid receptor agonist | |||
| 0.023 | 0.022 | 0.023 | Glutamate (mGluR1) agonist | |||
| 0.028 | 0.028 | 0.03 | Estrogen receptor alpha agonist | 0.03 0.026 DBMET01852 | DBMET01852 | |
| 0.089 | 0.09 | 0.114 | Adenylate kinase inhibitor | 0.114 0.049 DBMET01852 | DBMET01852 | |
| 0.106 | 0.107 | 0.112 | DNA repair enzyme inhibitor | 0.112 0.091 DBMET01852 | DBMET01852 | |
| 0.016 | 0.017 | 0.02 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.02 0.014 DBMET01852 | DBMET01852 | |
| 0.107 | 0.109 | 0.154 | Protein kinase stimulant | 0.154 0.066 DBMET01852 | DBMET01852 | |
| 0.062 | 0.066 | 0.068 | Aminopeptidase I inhibitor | 0.068 0.056 DBMET01852 | DBMET01852 | |
| 0.025 | 0.029 | 0.038 | Hedgehog signaling activator | 0.038 0.005 DBMET01852 | DBMET01852 | |
| 0.054 | 0.06 | 0.063 | Nitric oxide donor | 0.063 0.044 DBMET01852 | DBMET01852 | |
| 0.027 | 0.034 | 0.031 | Liver X receptor beta agonist | 0.031 0.026 DBMET01852 | DBMET01852 | |
| 0.018 | 0.026 | 0.024 | Prostaglandin F2 alpha agonist | 0.024 0.014 DBMET01852 | DBMET01852 | |
| 0.021 | 0.031 | 0.03 | Sodium/glucose cotransporter 2 inhibitor | 0.03 0.013 DBMET01852 | DBMET01852 | |
| 0.028 | 0.038 | 0.042 | HMG CoA reductase inhibitor | 0.042 0.012 DBMET01852 | DBMET01852 | |
| 0.147 | 0.158 | 0.17 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.17 0.108 DBMET01852 | DBMET01852 | |
| 0.077 | 0.088 | 0.096 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.096 0.059 DBMET01852 | DBMET01852 | |
| 0.075 | 0.089 | 0.086 | Alcohol dehydrogenase inhibitor | 0.086 0.069 DBMET01852 | DBMET01852 | |
| 0.062 | 0.075 | 0.106 | Glycine receptor agonist | 0.106 0.018 DBMET01852 | DBMET01852 | |
| 0.035 | 0.05 | 0.039 | Kainate receptor agonist | 0.039 0.033 DBMET01852 | DBMET01852 | |
| 0.039 | 0.054 | 0.054 | Cholesterol esterase inhibitor | 0.054 0.024 DBMET01852 | DBMET01852 | |
| 0.028 | 0.045 | 0.036 | Glutamate (mGluR3) antagonist | 0.036 0.026 DBMET01852 | DBMET01852 | |
| 0.021 | 0.037 | 0.031 | Sodium/glucose cotransporter inhibitor | 0.031 0.01 DBMET01852 | DBMET01852 | |
| 0.039 | 0.057 | 0.051 | Glucose-6-phosphate isomerase inhibitor | 0.051 0.028 DBMET01852 | DBMET01852 | |
| 0.047 | 0.073 | 0.076 | Phosphofructokinase-1 inhibitor | 0.076 0.043 DBMET01852 | DBMET01852 | |
| 0.008 | 0.035 | 0.015 | Ileal bile acid transport inhibitor | 0.015 0.014 DBMET01852 | DBMET01852 | |
| 0.03 | 0.057 | 0.038 | Glucose-6-phosphate dehydrogenase inhibitor | 0.038 0.025 DBMET01852 | DBMET01852 | |
| 0.005 | 0.032 | 0.011 | Thromboxane agonist | 0.011 0.008 DBMET01852 | DBMET01852 | |
| 0.056 | 0.084 | 0.07 | Glutamate dehydrogenase inhibitor | 0.07 0.057 DBMET01852 | DBMET01852 | |
| 0.018 | 0.049 | 0.033 | Prostaglandin agonist | 0.033 0.019 DBMET01852 | DBMET01852 | |
| 0.011 | 0.046 | 0.022 | Prostaglandin E2 agonist | 0.022 0.018 DBMET01852 | DBMET01852 | |
| 0.077 | 0.118 | 0.165 | DNA polymerase I inhibitor | 0.165 0.042 DBMET01852 | DBMET01852 | |
| 0.009 | 0.052 | 0.02 | Prostaglandin EP2 agonist | 0.02 0.018 DBMET01852 | DBMET01852 | |
| 0.047 | 0.091 | 0.055 | Lipocortins synthesis agonist | 0.055 0.048 DBMET01852 | DBMET01852 | |
| 0.043 | 0.093 | 0.063 | Transcription factor AP-1 inhibitor | 0.063 0.04 DBMET01852 | DBMET01852 | |
| 0.123 | 0.184 | 0.155 | Immunostimulant | 0.155 0.151 DBMET01852 | DBMET01852 | |
| 0.167 | 0.231 | 0.267 | Caspase 3 stimulant | 0.267 0.099 DBMET01852 | DBMET01852 | |
| 0.009 | 0.076 | 0.026 | RNA-directed RNA polymerase stimulant | 0.026 0.024 DBMET01852 | DBMET01852 | |
| 0.062 | 0.13 | 0.08 | NADH dehydrogenase inhibitor | 0.08 0.076 DBMET01852 | DBMET01852 | |
| 0.046 | 0.113 | 0.088 | Telomerase inhibitor | 0.088 0.04 DBMET01852 | DBMET01852 | |
| 0.032 | 0.101 | 0.053 | Carbamoyl phosphate synthetase inhibitor | 0.053 0.051 DBMET01852 | DBMET01852 | |
| 0.097 | 0.166 | 0.129 | Insulin secretagoues | 0.129 0.098 DBMET01852 | DBMET01852 | |
| 0.016 | 0.085 | 0.04 | Farnesoid X receptor agonist | 0.04 0.023 DBMET01852 | DBMET01852 | |
| 0.055 | 0.128 | 0.084 | Inducible nitric-oxide synthase inhibitor | 0.084 0.055 DBMET01852 | DBMET01852 | |
| 0.06 | 0.155 | 0.115 | Lanosterol 14 alpha demethylase inhibitor | 0.115 0.036 DBMET01852 | DBMET01852 | |
| 0.054 | 0.159 | 0.086 | ATPase (Vacuolar H+) inhibitor | 0.086 0.064 DBMET01852 | DBMET01852 | |
| 0.082 | 0.188 | 0.148 | Diuretic | 0.148 0.079 DBMET01852 | DBMET01852 | |
| 0.058 | 0.166 | 0.087 | Nitric-oxide synthase inhibitor | 0.087 0.084 DBMET01852 | DBMET01852 | |
| 0.042 | 0.165 | 0.085 | Glycine receptor antagonist | 0.085 0.05 DBMET01852 | DBMET01852 | |
| 0.096 | 0.219 | 0.204 | Interleukin agonist | 0.204 0.117 DBMET01852 | DBMET01852 | |
| 0.083 | 0.221 | 0.132 | NOS3 expression enhancer | 0.132 0.095 DBMET01852 | DBMET01852 | |
| 0.022 | 0.167 | 0.052 | Dopamine uptake inhibitor | 0.052 0.047 DBMET01852 | DBMET01852 | |
| 0.024 | 0.192 | 0.055 | Adrenaline uptake inhibitor | 0.055 0.051 DBMET01852 | DBMET01852 | |
| 0.121 | 0.302 | 0.18 | Peptidyltransferase inhibitor | 0.18 0.128 DBMET01852 | DBMET01852 | |
| 0.035 | 0.337 | 0.112 | Neurotrophic factor | 0.112 0.11 DBMET01852 | DBMET01852 | |
| 0.026 | 0.34 | 0.111 | Bronchodilator | 0.111 0.052 DBMET01852 | DBMET01852 | |
| 0.06 | 0.433 | 0.11 | Sphingosine 1-phosphate receptor 2 agonist | 0.11 0.075 DBMET01852 | DBMET01852 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |